ArticleJournal of family medicine and primary care2025
Dengue dynamics in India: Harnessing auto regressive integrated moving average model for predictive insights.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Seroprevalence of dengue virus infection in India.Bioinformation · 2026Article
- "Addressing rising dengue burden in Pakistan: is it time to consider dengue vaccination?"Annals of medicine and surgery (2012) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dengue, a mosquito-borne viral disease caused by the Dengue virus (DENV), poses a significant threat to global health. Nearly half of the world's population is at risk, with an estimated 100-400 million infections annually. South East Asian countries, including India, are particularly vulnerable due to their temperate climate and changing environmental conditions, leading to a rise in Dengue cases every year. Objectives: The current study was done to analyse the trend of Dengue in India and to forecast Dengue cases and deaths in India. Methods: The study employed a time series analysis approach, collecting Dengue data from 1999 to 2023 from the National Health Profile and NVBCDCP. Gretl software was used to develop an appropriate ARIMA (Auto Regressive Integrated Moving Average) model based on the available data to forecast Dengue cases and deaths. The model was checked for stationarity and used to predict Dengue cases and deaths for the next 3 years (2024-2026). Results: The analysis revealed an increasing trend in Dengue cases and deaths in India over the study period. The forecasted data for 2024-2026 also indicate a continued rise in both cases and deaths. The projected Dengue cases for 2026 are 309,836 (95% CI; 240,337-379,334), while the projected deaths are 533 (95% CI; 285-781). Conclusion: The increasing trend in Dengue burden highlights the urgent need for targeted interventions to mitigate the public health impact. Hence, it is recommended that the policymakers and health authorities must prioritize the planning and implementation of effective preventive measures to curb the increasing trend of Dengue in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.